Literature DB >> 29921203

Current Therapeutic Strategy in the Nasal Delivery of Insulin: Recent Advances and Future Directions.

Jiawei Chen1,2, Liandong Hu1,2, Guang Yang1,2, Qiaofeng Hu2,3.   

Abstract

BACKGROUND: Insulin (INS) has been used in the treatment of diabetes mellitus. Due to its large molecular weight and short half-life, it has been usually administered subcutaneously accompanied with side effects such as the possibility of hypoglycemia episodes, weight gain and inadequate post-meal glucose control.
OBJECTIVE: In order to overcome these limitations, alternative delivery routes of insulin are expected to provide better safety and compliance for the patient. Non-invasive insulin delivery system represents one of the most challenging goals for pharmaceutical industry. Nasal insulin delivery has been extensively studied as an alternative to subcutaneous injection for the treatment of diabetes. The pharmacokinetic profile of nasal insulin is similar to that obtained by intravenous injection. RESULT &
CONCLUSION: This review discusses the most recent developments in nasal insulin administration technology. Firstly, the structure and physiology of the nasal cavity are introduced. Then, the advantages and disadvantages of nasal administration are discussed. Next, the methods of enhancing nasal insulin absorption and the dosage forms for insulin nasal administration are described. Furthermore, new therapeutic indications of nasal insulin administration were also investigated. Finally, the future development and respective technology of nasal insulin administration are prospected. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Insulin; drug delivery systems; humans insulin dosage; nasal administration; nasal biological transport; noninvasivezzm321990insulin delivery.

Mesh:

Substances:

Year:  2018        PMID: 29921203     DOI: 10.2174/1389201019666180619145429

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  4 in total

Review 1.  Different Methods and Formulations of Drugs and Vaccines for Nasal Administration.

Authors:  Junhu Tai; Munsoo Han; Dabin Lee; Il-Ho Park; Sang Hag Lee; Tae Hoon Kim
Journal:  Pharmaceutics       Date:  2022-05-17       Impact factor: 6.525

Review 2.  Insulin-delivery methods for children and adolescents with type 1 diabetes.

Authors:  Zavuga Zuberi; Elingarami Sauli; Liu Cun; Jing Deng; Wen-Jun Li; Xu-Liang He; Wen Li
Journal:  Ther Adv Endocrinol Metab       Date:  2020-05-08       Impact factor: 3.565

Review 3.  Nanofiber-based systems intended for diabetes.

Authors:  Hassan Maleki; Kamyar Khoshnevisan; Sayed Mahmoud Sajjadi-Jazi; Hadi Baharifar; Maryam Doostan; Nazanin Khoshnevisan; Farshad Sharifi
Journal:  J Nanobiotechnology       Date:  2021-10-12       Impact factor: 10.435

Review 4.  Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations.

Authors:  Melissa Kirkby; Aaron R J Hutton; Ryan F Donnelly
Journal:  Pharm Res       Date:  2020-06-02       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.